Table 1 Clinico-pathological characteristics of WT Bf-CM patients
Groups | Total (N = 211) | Training Group (N = 106) | Test Group (N = 105) |
|---|---|---|---|
Gender | |||
 Male | 135(64.0%) | 73(68.9%) | 62(59.0%) |
 Female | 76(36.0%) | 33(31.1%) | 43(41.0% |
Age At Diagnosis | |||
 Median | 62 | 63.5 | 61 |
 Range | 25 ~ 87 | 30 ~ 87 | 25 ~ 83 |
 ≤ 58 | 90(42.7%) | 42(39.6%) | 48(45.7%) |
 > 58 | 121(57.3%) | 64(60.3%) | 57(54.3%) |
Tumor Tissue Site | |||
 Primary Tumor | 38(18.0%) | 20(18.9%) | 18(17.10%) |
 Regional Cutaneous Or Subcutaneous Tissue | 38(18.0%) | 21(19.8%) | 17(16.20%) |
 Regional Lymph Node Metastasis | 93(44.1%) | 46(43.4%) | 47(44.80%) |
 Distant Metastasis | 40(19.0%) | 18(17.0%) | 22(21.00%) |
 Unknown | 2(0.9%) | 1(0.9%) | 1(1.00%) |
Pathological Stage | |||
 0 | 4(1.9%) | 1(0.9%) | 3(2.90%) |
 I | 35(16.6%) | 13(12.3%) | 22(21.00%) |
 II | 63(29.9%) | 33(31.1%) | 30(28.60%) |
 III | 83(39.3%) | 43(40.6%) | 40(38.10%) |
 IV | 8(3.8%) | 4(3.8%) | 4(3.80%) |
 Unknown | 18(8.5%) | 12(11.3%) | 6(5.70%) |
Anatomic Site | |||
 Head And Neck | 16(7.6%) | 8(7.5%) | 8(7.60%) |
 Extremities | 108(51.2%) | 55(51.9%) | 53(50.50%) |
 Trunk | 56(26.5%) | 28(26.4%) | 28(26.70%) |
 Others/Unknown | 31(14.7%) | 15(14.2%) | 16(15.20%) |
Breslow Thickness (mm) | |||
  < 2 | 54(25.5%) | 26(24.6%) | 28(26.70%) |
 2 ~ 5 | 60(28.5%) | 36(33.9%) | 24(22.80%) |
  > 5 | 53(25.1%) | 25(23.6%) | 28(26.70%) |
 Unknown | 44(20.9%) | 19(17.9%) | 25(23.80%) |
Radiation Therapy | |||
 Yes | 37(17.5%) | 20(18.9%) | 17(16.20%) |
 No | 155(73.5%) | 75(70.8%) | 80(76.20%) |
 Unknown | 19(9.00%) | 11(10.40%) | 8(7.60%) |
Vital Status | |||
 Yes | 81(38.4%) | 36(34.0%) | 45(42.90%) |
 No | 130(61.6%) | 70(66.0%) | 60(57.10%) |